CD55 抗体
Quick Overview for CD55 抗体 (ABIN2480961)
抗原
See all CD55 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
产品特性
- Purified IgG
-
纯化方法
- Purified
-
免疫原
- Human fibroblast cell line
-
亚型
- IgG1
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1.0 mg/mL
-
-
-
: "Inhibition of decay-accelerating factor (CD55) attenuates prostate cancer growth and survival in vivo." in: Neoplasia (New York, N.Y.), Vol. 8, Issue 1, pp. 69-78, (2006) (PubMed).
: "Modeling how CD46 deficiency predisposes to atypical hemolytic uremic syndrome." in: Molecular immunology, Vol. 44, Issue 7, pp. 1559-68, (2006) (PubMed).
-
: "Inhibition of decay-accelerating factor (CD55) attenuates prostate cancer growth and survival in vivo." in: Neoplasia (New York, N.Y.), Vol. 8, Issue 1, pp. 69-78, (2006) (PubMed).
-
- CD55 (Complement Decay-Accelerating Factor (CD55))
-
别名
- CD55
-
背景
- Synonyms: DAF
-
基因ID
- 1604
-
UniProt
- P08174
-
途径
- Complement System, Regulation of Leukocyte Mediated Immunity
抗原
-